Medicare insulin fills increased after Inflation Reduction Act’s $35 out-of-pocket cap
More Medicare enrollees got their insulin prescriptions filled following the Inflation Reduction Act’s $35 cap on out-of-pocket expenses for the medicine compared to the prior year, according to a new study co-authored by a University of Wisconsin researcher.
To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.